PRODUCT DETAIL

KARDATUXAN 2,5 mg filmom obalené tablety

Code

3137E

MA number

16/0047/23-S

Product Form:

tbl flm 100x2,5 mg (blis.OPA/Al/PVC/Al)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

Gedeon Richter Plc., Hungary

Therapeutic Class:

16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)

ATC:

B	BLOOD AND BLOOD FORMING ORGANS
B01	ANTITHROMBOTIC AGENTS
B01A	ANTITHROMBOTIC AGENTS
B01AF	Direct factor Xa inhibitors
B01AF01	Rivaroxaban

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	22.03.2023
Validity:	22.03.2028
SPC:	SPC_KARDATUXAN 2,5 mg filmom obalené tablety_11.2023.pdf
PIL:	PIL_KARDATUXAN 2,5 mg filmom obalené tablety_11.2023.pdf
Safety feature	Yes
Data update:	24.03.2023